229 related articles for article (PubMed ID: 17434304)
1. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
[TBL] [Abstract][Full Text] [Related]
2. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
Schnute ME; Brideau RJ; Collier SA; Cudahy MM; Hopkins TA; Knechtel ML; Oien NL; Sackett RS; Scott A; Stephan ML; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2008 Jul; 18(14):3856-9. PubMed ID: 18595689
[TBL] [Abstract][Full Text] [Related]
4. 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
Larsen SD; Zhang Z; DiPaolo BA; Manninen PR; Rohrer DC; Hageman MJ; Hopkins TA; Knechtel ML; Oien NL; Rush BD; Schwende FJ; Stefanski KJ; Wieber JL; Wilkinson KF; Zamora KM; Wathen MW; Brideau RJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3840-4. PubMed ID: 17513108
[TBL] [Abstract][Full Text] [Related]
5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
6. Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
Nieman JA; Nair SK; Heasley SE; Schultz BL; Zerth HM; Nugent RA; Chen K; Stephanski KJ; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Wathen MW
Bioorg Med Chem Lett; 2010 May; 20(10):3039-42. PubMed ID: 20403696
[TBL] [Abstract][Full Text] [Related]
7. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
[TBL] [Abstract][Full Text] [Related]
8. Non-nucleoside inhibitors of herpesviruses.
Wathen MW
Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy.
Loregian A; Palù G
Clin Microbiol Infect; 2005 Jun; 11(6):437-46. PubMed ID: 15882193
[TBL] [Abstract][Full Text] [Related]
10. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
13. Herpesviridae and novel inhibitors.
Siakallis G; Spandidos DA; Sourvinos G
Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
[TBL] [Abstract][Full Text] [Related]
14. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).
Véron JB; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2007 Nov; 15(22):7209-19. PubMed ID: 17869124
[TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.
Oien NL; Brideau RJ; Hopkins TA; Wieber JL; Knechtel ML; Shelly JA; Anstadt RA; Wells PA; Poorman RA; Huang A; Vaillancourt VA; Clayton TL; Tucker JA; Wathen MW
Antimicrob Agents Chemother; 2002 Mar; 46(3):724-30. PubMed ID: 11850254
[TBL] [Abstract][Full Text] [Related]
16. Interactions between virus and antiviral compounds in the host cell.
Harmenberg J
Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
[No Abstract] [Full Text] [Related]
17. Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.
Falardeau G; Lachance H; St-Pierre A; Yannopoulos CG; Drouin M; Bédard J; Chan L
Bioorg Med Chem Lett; 2005 Mar; 15(6):1693-5. PubMed ID: 15745823
[TBL] [Abstract][Full Text] [Related]
18. Pyrazolopyridines with potent activity against herpesviruses: effects of C5 substituents on antiviral activity.
Gudmundsson KS; Johns BA; Allen SH
Bioorg Med Chem Lett; 2008 Feb; 18(3):1157-61. PubMed ID: 18086523
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of novel erythrofuranosyl imidazo[1,2-a]pyridine C-nucleosides constructed via palladium coupling of iodoimidazo[1,2-a]pyridines and dihydrofuran.
Gudmundsson KS; Williams JD; Drach JC; Townsend LB
J Med Chem; 2003 Apr; 46(8):1449-55. PubMed ID: 12672244
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic etheno analogs of PMEG and PMEDAP: synthesis and biological activity.
Horejsí K; Andrei G; De Clercq E; Snoeck R; Pohl R; Holý A
Bioorg Med Chem; 2006 Dec; 14(23):8057-65. PubMed ID: 16904327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
